Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

Overview of attention for article published in Journal of Neurology, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 1 blog post.

#MSBlog: How soon after stopping natalizumab (Tysabri) do you start fingolimod (Gilenya)?Epub: Havla et al. Fingolimod reduces…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.